Lindsey M Duca1, Beth A Reboussin2, Catherine Pihoker3, Giuseppina Imperatore4, Sharon Saydah4, Elizabeth Mayer-Davis5, Arleta Rewers6, Dana Dabelea1. 1. Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 2. Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina. 3. Department of Pediatrics, University of Washington, Seattle, Washington. 4. Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia. 5. Department of Nutrition and Medicine, Gillings School of Global Public Health and School of Medicine, University of North Carolina, Chapel Hill, North Carolina. 6. Department of Pediatrics, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado.
Abstract
BACKGROUND: The diagnosis of type 1 diabetes (T1D) in youth is often associated with diabetic ketoacidosis (DKA). We aimed to evaluate if the presence of DKA at diagnosis of T1D is associated with less favorable hemoglobin A1c (HbA1c) trajectories over time. METHODS: The SEARCH for Diabetes in Youth study of 1396 youth aged <20 years with newly diagnosed T1D were followed for up to 13 (median 8 [interquartile range or IQR 6-9]) years after diagnosis. Of these, 397 (28%) had DKA (bicarbonate level < 15 mmol/L and/or pH < 7.25 (venous) or < 7.30 (arterial or capillary) or mention of DKA in medical records) at diabetes onset. Longitudinal HbA1c levels were measured at each follow-up visit (average number of HbA1c measures 3.4). A linear piecewise mixed effects model was used to analyze the effect of DKA status at diagnosis of T1D on long-term glycemic control, adjusting for age at diagnosis, diabetes duration at baseline, sex, race/ethnicity, household income, health insurance status, time-varying insulin regimen and glucose self-monitoring, study site, and baseline fasting C-peptide level. RESULTS: At baseline, HbA1c levels were significantly higher in youth with T1D diagnosed in DKA vs those who were not (9.9% ± 1.5% vs 8.5% ± 1.4%, respectively). After the first year with diabetes, there was a significant difference in the rate of change in HbA1c levels by DKA status: HbA1c was 0.16% higher each year in youth with DKA compared to those without (interaction P-value<0.0001), after adjusting for aforementioned covariates. CONCLUSIONS: DKA at T1D diagnosis is associated with worsening glycemic control over time, independent of demographic, socioeconomic, and treatment-related factors and baseline fasting C-peptide.
BACKGROUND: The diagnosis of type 1 diabetes (T1D) in youth is often associated with diabetic ketoacidosis (DKA). We aimed to evaluate if the presence of DKA at diagnosis of T1D is associated with less favorable hemoglobin A1c (HbA1c) trajectories over time. METHODS: The SEARCH for Diabetes in Youth study of 1396 youth aged <20 years with newly diagnosed T1D were followed for up to 13 (median 8 [interquartile range or IQR 6-9]) years after diagnosis. Of these, 397 (28%) had DKA (bicarbonate level < 15 mmol/L and/or pH < 7.25 (venous) or < 7.30 (arterial or capillary) or mention of DKA in medical records) at diabetes onset. Longitudinal HbA1c levels were measured at each follow-up visit (average number of HbA1c measures 3.4). A linear piecewise mixed effects model was used to analyze the effect of DKA status at diagnosis of T1D on long-term glycemic control, adjusting for age at diagnosis, diabetes duration at baseline, sex, race/ethnicity, household income, health insurance status, time-varying insulin regimen and glucose self-monitoring, study site, and baseline fasting C-peptide level. RESULTS: At baseline, HbA1c levels were significantly higher in youth with T1D diagnosed in DKA vs those who were not (9.9% ± 1.5% vs 8.5% ± 1.4%, respectively). After the first year with diabetes, there was a significant difference in the rate of change in HbA1c levels by DKA status: HbA1c was 0.16% higher each year in youth with DKA compared to those without (interaction P-value<0.0001), after adjusting for aforementioned covariates. CONCLUSIONS: DKA at T1D diagnosis is associated with worsening glycemic control over time, independent of demographic, socioeconomic, and treatment-related factors and baseline fasting C-peptide.
Authors: Dana Dabelea; Arleta Rewers; Jeanette M Stafford; Debra A Standiford; Jean M Lawrence; Sharon Saydah; Giuseppina Imperatore; Ralph B D'Agostino; Elizabeth J Mayer-Davis; Catherine Pihoker Journal: Pediatrics Date: 2014-03-31 Impact factor: 7.124
Authors: Dana Dabelea; Jeanette M Stafford; Elizabeth J Mayer-Davis; Ralph D'Agostino; Lawrence Dolan; Giuseppina Imperatore; Barbara Linder; Jean M Lawrence; Santica M Marcovina; Amy K Mottl; Mary Helen Black; Rodica Pop-Busui; Sharon Saydah; Richard F Hamman; Catherine Pihoker Journal: JAMA Date: 2017-02-28 Impact factor: 56.272
Authors: D Dabelea; E J Mayer-Davis; J S Andrews; L M Dolan; C Pihoker; R F Hamman; C Greenbaum; S Marcovina; W Fujimoto; B Linder; G Imperatore; R D'Agostino Journal: Diabetologia Date: 2012-09-20 Impact factor: 10.122
Authors: Henrik B Mortensen; Peter G F Swift; Reinhard W Holl; P Hougaard; Lars Hansen; Hilde Bjoerndalen; Carine E de Beaufort; Michael Knip Journal: Pediatr Diabetes Date: 2008-08-25 Impact factor: 4.866
Authors: Richard F Hamman; Ronny A Bell; Dana Dabelea; Ralph B D'Agostino; Lawrence Dolan; Giuseppina Imperatore; Jean M Lawrence; Barbara Linder; Santica M Marcovina; Elizabeth J Mayer-Davis; Catherine Pihoker; Beatriz L Rodriguez; Sharon Saydah Journal: Diabetes Care Date: 2014-12 Impact factor: 19.112
Authors: Federica Piani; Isabella Melena; Cameron Severn; Linh T Chung; Carissa Vinovskis; David Cherney; Laura Pyle; Carlos A Roncal-Jimenez; Miguel A Lanaspa; Arleta Rewers; Daniël H van Raalte; Wassim Obeid; Chirag Parikh; Robert G Nelson; Meda E Pavkov; Kristen J Nadeau; Richard J Johnson; Petter Bjornstad Journal: Pediatr Diabetes Date: 2021-09-06 Impact factor: 4.866
Authors: Dana Dabelea; Katherine A Sauder; Elizabeth T Jensen; Amy K Mottl; Alyssa Huang; Catherine Pihoker; Richard F Hamman; Jean Lawrence; Lawrence M Dolan; Ralph D' Agostino; Lynne Wagenknecht; Elizabeth J Mayer-Davis; Santica M Marcovina Journal: Ann N Y Acad Sci Date: 2021-02-05 Impact factor: 6.499
Authors: Pradeep A Praveen; Christine W Hockett; Toan C Ong; Anandakumar Amutha; Scott P Isom; Elizabeth T Jensen; Viswanathan Mohan; Dana A Dabelea; Ralph B D'Agostino; Richard F Hamman; Elizabeth J Mayer-Davis; Jean M Lawrence; Lawrence M Dolan; Michael G Kahn; Sri Venkata Madhu; Nikhil Tandon Journal: Pediatr Diabetes Date: 2020-02-17 Impact factor: 3.409